Does RITUXIMAB Cause Bladder transitional cell carcinoma? 74 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Bladder transitional cell carcinoma have been filed in association with RITUXIMAB (Rituxan). This represents 0.0% of all adverse event reports for RITUXIMAB.
74
Reports of Bladder transitional cell carcinoma with RITUXIMAB
0.0%
of all RITUXIMAB reports
1
Deaths
55
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From RITUXIMAB?
Of the 74 reports, 1 (1.4%) resulted in death, 55 (74.3%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 74 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
RANITIDINE (41)
Which RITUXIMAB Alternatives Have Lower Bladder transitional cell carcinoma Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE